UBS maintains Neutral rating on AbbVie with PT down to $230.

Thursday, Feb 5, 2026 10:39 am ET1min read
ABBV--

UBS maintains Neutral rating on AbbVie with PT down to $230.

UBS maintains Neutral rating on AbbVie with PT down to $230.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet